Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 10:12
Estrella Immunopharma Total Liabilities (Quarterly) : 9.256M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.256M |
| March 31, 2026 | 8.928M |
| December 31, 2025 | 13.54M |
| September 30, 2025 | 13.36M |
| June 30, 2025 | 9.075M |
| March 31, 2025 | 4.275M |
| December 31, 2024 | 2.997M |
| September 30, 2024 | 2.989M |
| June 30, 2024 | 0.1807M |
| March 31, 2024 | 0.1385M |
| December 31, 2023 | 0.3987M |
| Date | Value |
|---|---|
| September 30, 2023 | 17.28M |
| June 30, 2023 | 3.326M |
| March 31, 2023 | 3.084M |
| December 31, 2022 | 2.916M |
| September 30, 2022 | 2.286M |
| June 30, 2022 | 1.705M |
| March 31, 2022 | 1.581M |
| December 31, 2021 | 1.624M |
| September 30, 2021 | 1.651M |
| June 30, 2021 | 3.42M |
| February 28, 2021 | 0.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.825M |
| Shareholders Equity (Quarterly) | -7.431M |
| Current Ratio | 0.1971 |